FHOD3

Chr 18AD

formin homology 2 domain containing 3

Also known as: CMH28, FHOS2, Formactin2

FHOD3 encodes a formin protein that regulates actin filament polymerization in cardiomyocytes and controls cell morphology, cytoskeletal organization, and developmental angiogenesis. Mutations cause familial hypertrophic cardiomyopathy with autosomal dominant inheritance. The gene shows significant constraint against loss-of-function variants (LOEUF 0.374), reflecting its essential role in cardiac muscle function.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

Cardiomyopathy, familial hypertrophic, 28MIM #619402
AD
0
Active trials
11
Pubs (1 yr)
21
P/LP submissions
13%
P/LP missense
0.37
LOEUF
DN
Mechanism· predicted
Clinical SummaryFHOD3
🧬
Gene-Disease Validity (ClinGen)
hypertrophic cardiomyopathy · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.25) despite low pLI — interpret in context.
📋
ClinVar Variants
15 unique Pathogenic / Likely Pathogenic· 210 VUS of 400 total submissions
📖
GeneReview available — FHOD3
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.37LOEUF
pLI 0.067
Z-score 5.63
OE 0.25 (0.170.37)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
0.88Z-score
OE missense 0.91 (0.860.97)
742 obs / 812.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.25 (0.170.37)
00.351.4
Missense OE0.91 (0.860.97)
00.61.4
Synonymous OE1.02
01.21.6
LoF obs/exp: 16 / 65.0Missense obs/exp: 742 / 812.3Syn Z: -0.28
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveFHOD3-related hypertrophic cardiomyopathyOTHERAD
DN
0.6357th %ile
GOF
0.6053th %ile
LOF
0.3843th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

400 submitted variants in ClinVar

Classification Summary

Pathogenic9
Likely Pathogenic6
VUS210
Likely Benign51
Benign96
Conflicting4
9
Pathogenic
6
Likely Pathogenic
210
VUS
51
Likely Benign
96
Benign
4
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
9
0
9
Likely Pathogenic
2
2
2
0
6
VUS
4
195
9
2
210
Likely Benign
0
17
8
26
51
Benign
0
4
79
13
96
Conflicting
4
Total621810741376

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

FHOD3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →